SGHT (Sight Sciences, Inc) Company Projected Revenue

Brandmark of Sight Sciences, Inc (SGHT)

The GURU.Markets terminal features a chart of the projected sales volume, where the latest value is recorded as 0.09. This trend for Sight Sciences, Inc. (SGHT) is driven by the popularity of the OMNI system and the implementation of TearCare. High margins are based on the uniqueness of its glaucoma tools. The stability of operating metrics relies on the expansion of insurance coverage and steady demand for ophthalmological interventions.

SGHT - Sight Sciences Inc Company Expected Sales Volume over the range 07/04/2022 - 11/17/2026

Analytical breakdowns and data insights for company Sight Sciences, Inc (SGHT)

- current price and projected stock value:
Fundamental company analysis:sightsciences.com
Brand item of Sight Sciences Inc.

Amid intense competition with medtech giants for the loyalty of ophthalmologists, sales volume expectations for Sight Sciences, Inc. (SGHT) reflect market confidence in the resilience of the company's commercial model. This indicator synthesizes the projected revenue stream, assessing the business's ability to generate income under stress scenarios, which allows investors to identify risks of a sharp decline in demand for innovative glaucoma treatment devices.

Analysis of competing companies

Company Projected Revenue Boston Scientific Corp (BSX)|EW - Company Expected Sales Volume|Projected Sales Volume RMD (resmed.com)|PODD - Company Future Sales Volume|Zimmer Biomet Holdings, Inc. - Projected Sales Volume|COO (The Cooper Companies) - Company Revenue Forecast|ALGN: Projected Sales Volume|Company Revenue Forecast GMED|TMDX (TransMedics Corp) - Projected Sales Volume|ATEC Spine (ATEC) - Company Future Sales|Projected Sales Volume AORT|Company Future Sales Volume Enovis Corporation ENOV|Projected Sales Volume IART (integralife.com)|Projected Sales Volume Establishment Labs Corp ESTA|BBNX - Company Projected Revenue|IRMD: Company Projected Revenue|EMBC (Embecta Corp.) - Company Future Sales Volume|Tandem Diabetes Care - Company Future Revenue|AXGN (Axogen Surgical) - Projected Sales Volume|Company Expected Sales Volume SI-BONE Inc SIBN|Company Projected Revenue Orthofix Medical (OFIX)|Projected Sales Volume Bioventus Corp (BVS)|OrthoPediatrics Corp - Company Future Sales Volume|Projected Sales Volume Treace Medical Concepts TMCI|Blade Air Mobility - Projected Sales Volume|Company Future Sales Carlsmed, Inc. CARL|RxSight (RXST) - Company Projected Revenue|Company Expected Revenue CLPT (ClearPoint)|Company Projected Revenue stereotaxis.com|Company Future Sales Volume Neuronetics, Inc. (STIM)|Projected Sales Volume OBIO|ANIK - Company Expected Sales Volume|Company Projected Revenue InspireMD, Inc. NSPR|ZJYL: Company Revenue Forecast|VANI: Company Future Sales Volume|Xtant Medical Holdings, Inc. - Company Projected Revenue Volume|NeuroOne Corp (NMTC) - Company Projected Revenue|Company Future Sales Volume Modular Med|Company Projected Revenue myomo.com|Company Revenue Forecast COCH (Envoy Medical, Inc.)|Company Future Sales Volume VVOS (Vivos Therapeutics)|Company Projected Revenue NVNO (enVVeno Medical Corp.)|Sintx Technologies, Inc. - Company Future Sales Volume|Tenon Medical Inc. (TNON) - Company Expected Sales Volume|LFWD - Company Projected Revenue|AMIX (Autonomix Medical) - Company Revenue Forecast|IVF: Projected Sales Volume|BBLG (Bone Biologics) - Company Projected Revenue|Company Projected Revenue Axonics Inc.|Company Expected Sales Volume Biolase, Inc. BIOL|Company Projected Revenue Dynatronics Corp. (DYNT)|FNA (Paragon 28 Corp) - Company Future Revenue|Company Projected Revenue invobioscience.com INVO